Member Info for Trickymatters

No idea wtf you're talking about. Not interested in your row with someone else. I am interested in you cross ramping a share with majority Russian assets. **** off you gross excuse for a human being. Still trying to blur the boundaries.

I am not 'playing with myself in front of the mirror' investorsknowsnowt, you absolute ****fest. You are promoting Russian assets in the middle of a war. I most certainly know about Poly. 52% of it's goldmines are in Russia. They pay taxes to Putin. The whole board has resigned due to the war. Stop cross ramping your disgusting investment.

Investorintheknow, this is the RR. board. You're clearly not in the know. Poly are down to £1.69 from £12 in the last month because half their assets are in Russia. Johnson is proposing banning Russian gold today. Don't promote Russian assets on this board. There's a war on. Not all investors are walking moral vacuums. You will lose all your money anyway you plonker.

And RR. staying flat? Should fly on the next RNS surely?

Rest assured Maplinman, we don't want the benefit of your atrocious views on the war in Ukraine. Focus on your investment if you have one here.

Maplinman,

I will buy some more this week. Sold on Friday's rise because I didn't think mms would let that rise hold. The next news will be PALOH discussing and promoting the findings and their future plans. They said we will hear more this week. Professor Newman says this will be rolled out across the NHS. So that should work for the sp I expect.

Yes. Me too. Good news yesterday from the nuclear energy roundtable re SMTs investment expectations. Maybe no-one trusts anything Johnson says now. NATO meeting this week should have an impact?

Sounds good.

Well Johnson said he's 'not quite dreaming of every household having their own SMR in the garden but something like that'... So pretty positive.

RR. are at the roundtable aren't they? Anyone else think they might get a deal this week?

Don't come back Penny. You never shared anything useful. You have been a truly negative presence.

They test hundreds of thousands to find the 90,000 who are allergic to the drug they give all babies to protect from sepsis.

Yeah. Professor Newman said this will be rolled out across the NHS. Many more of these RNS' to come. The technology will be adapted for other kinds of genetic tests going forward- they are commercialising their machines. Hugely important. Wonder if we will make the news?

Don't let nonsense dictate the conversation please guys and gals.

How lovely! £60 a test. X the number of babies born every year + the main systems x 6 for 2 hospitals. So × 3 of the number of UK neonatal hospitals.

It's an absolute must watch. I am so pleased that the trials were successful. G8 that investors have got the heads up. Takes a lot of risk out of the investment. Wish I was getting in at this price. Lol! New investors will multi-bag from here. My average isn't too bad though. So fairly satisfied with my outlook. Expecting to exceed a double bag in the next few weeks.

Personalised medicine has been the vision for some time. Unsurprising how excited Professor Newman is to be at the start of what will be such an important influence for medicine in the future. It will reduce the pain of getting the wrong kind of meds, whether it's antidepressants, HRT or something to prevent sepsis. In the case of the latter a mistake for babies with allergies will lead to deafness so Genedrive's test is already a massive result for 90,000 babies who are at risk.
Personalised medicine using a genetic reference test for everyone, as Professor Bill Newman discusses will save all of us time, worry and it will save the NHS multi-million pounds.
I think they will definitely see Genedrive as the go to partner for other iterations in the future.

Are retweeting my tweets now. Interesting.

18p on the ask so level 2 looks like people are lining up to buy Jay. I am going to filter you if you keep acting like a prat though.
A couple of us have an alert on for the next PALOH update. Yikes! Feel a bit excited. Love the way that Professor Bill Newman is discussing this as the first active initiative for personalised health care. Love the fact that we know it's been successful and it will be rolled out across the NHS and we know there's already interest in the US, Australia and Holland.